2016
Orthostatic hypotension in diabetic patients-10-year follow-up study
GASPAR, Ludovit; Peter KRUŽLIAK; Andrea KOMORNIKOVA; Zuzana CELECOVA; Boris KRAHULEC et al.Základní údaje
Originální název
Orthostatic hypotension in diabetic patients-10-year follow-up study
Autoři
GASPAR, Ludovit; Peter KRUŽLIAK; Andrea KOMORNIKOVA; Zuzana CELECOVA; Boris KRAHULEC; David BALAZ; Peter SABAKA; Martin CAPRNDA; Marek KUCERA; Luis RODRIGO; Yoshio UEHARA a Andrej DUKAT
Vydání
Journal of Diabetes and its Complications, USA, Elsvier Science, 2016, 1056-8727
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30202 Endocrinology and metabolism
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 2.734
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/16:00089533
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Diabetes mellitus; Diabetic cardiovascular autonomic neuropathy; Orthostatic hypotension; Microvascular and macrovascular complications; Mortality
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 4. 8. 2016 14:46, Ing. Mgr. Věra Pospíšilíková
Anotace
V originále
Introduction: Cardiovascular autonomic neuropathy in diabetics is a common but often underestimated and underdiagnosed complication of diabetes mellitus. One of the most clinical apparent forms of cardiovascular autonomic neuropathy is orthostatic hypotension. Objectives: To retrospectively assess the association of the orthostatic hypotension (OH) with macrovascular and microvascular complications of diabetes mellitus and to determine its effect on mortality. Design and methods: We retrospectively analyzed 187 patients with diabetes mellitus (60 patients with diabetes type 1 and 127 patients with diabetes type 2). Patients were divided into groups according to presence or absence of OH and type of diabetes. Association of OH with macrovascular and microvascular complications was evaluated and the effect of OH on 10-year all-cause mortality was also assessed. Results: OH was present in 31.7% of patients with diabetes type 1 (DM1) and in 32.3% of patients with diabetes type 2 (DM2). OH was positively associated with the prevalence of myocardial infarction in DM1 (OR = 10.67) and with prevalence of stroke in DM2 (OR = 3.33). There was also a strong association of OH and the prevalence of peripheral artery disease in both DM1 (OR = 14.18) and DM2 (OR = 3.26). Patients with both types of diabetes and OH had significantly higher prevalence of nephropathy (DM1 OR = 8.68, DM2 OR = 324), retinopathy (DM1 OR = 8.09, DM2 OR = 4.08) and peripheral neuropathy (DM1 OR = 17.14, DM2 OR = 7.51) Overall 10 year mortality rate was higher in diabetic patients with OH. Conclusions: Presence of OH in diabetics is associated with higher prevalence of macrovascular and microvascular complications of diabetes mellitus and also with higher 10-year mortality.